Cancer Home > Velcade and Breastfeeding
It is unknown if Velcade (bortezomib) passes through breast milk or if it would cause problems in the nursing infant. However, based on the properties of this drug, it might pass through breast milk to some extent. Due to the fact that this medication has the potential to cause dangerous complications, the manufacturer advises that women avoid breastfeeding during Velcade treatment.
Can Breastfeeding Women Use Velcade?Velcade® (bortezomib) is an injectable prescription chemotherapy medication. It is unknown if Velcade passes through breast milk. Therefore, if you are breastfeeding or plan to start, discuss this with your healthcare provider before receiving this medicine.
More Information About Velcade and BreastfeedingThere is very little information available about Velcade and breastfeeding, as the medication has not been studied in women who are nursing. Therefore, it is unknown if the medicine passes through breast milk or would harm a nursing child.
Based on the properties of the drug, it can be expected to pass through breast milk to some extent. Because Velcade is associated with potentially serious side effects, such as a decrease in blood cell counts, nausea, and vomiting, it may be best to avoid breastfeeding during treatment.
The manufacturer recommends women not breastfeed during treatment. Velcade is usually dosed on a rotating schedule that includes a period of 10 to 13 days when the medication is not given. It is unknown whether breastfeeding is safe during these breaks.
If your healthcare provider recommends breastfeeding while you are using Velcade, make sure to keep a close eye on your child for any potential side effects. Let your child's healthcare provider know if something does not seem right with your child, or if you notice any possible Velcade side effects, such as:
- Low energy
- Unusual bruising or bleeding
- Difficulty breathing
- Difficulty eating or decreased appetite
- Excessive crying.